Natera Wins US Verdict in Cancer-Detection Patent Case

Genetic testing company Natera Inc convinced a Delaware federal jury on Monday to award it $19.3 million in damages from Invitae Corp's ArcherDX for infringing patents related to cancer detection.

Related Keywords

Delaware ,United States ,Washington ,Gregory Williams ,Natera Signatera ,Blake Brittain ,Archerdx Inc ,Reuters ,Invitae Corp Archer ,Natera Inc ,Us District Court ,Invitae Corp ,San Francisco Based Invitae ,Texas Based Natera ,Judge Gregory Williams ,Genomics ,Genomic Medicine ,Edicine Genomic ,Cancer ,Alignant Neoplasia ,Arcinoma ,Genetic Testing ,Genetics ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Biomedical Technology ,Biotechnology ,Blood ,